Chronic Hepatitis B immunotherapeutic Vaccine Given Approval to Begin Trials
Global biopharmaceutical company YS Biopharma Co. announced last week that its investigational YS-HBV-002 immunotherapeutic vaccine, designed to treat patients suffering from chronic hepatitis B infection, was granted clinical trial approval by the …